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Here, we report a case of a 41-year-old male diagnosed as septic shock with purpura fulminans (PF) infection. The
causative organism was β-lactamase-negative ampicillin-resistant Hemophilus influenzae. He developed fulminant
cardiac dysfunction approximately 1 h after admission, and the cause was considered to be septic cardiomyopathy.
Blood pressure and oxygenation were maintained at adequate levels with the aid of extracorporeal membrane
oxygenation (ECMO). The cardiac dysfunction was reversible, and he was successfully weaned from ECMO on day
12 of hospitalization. However, he needed amputation for all extremities because the infection spread to his
limbs and eventually, succumbed to sepsis caused by empyema on day 34 of hospitalization. To the best of our
knowledge, this is only the second case of PF caused by H. influenzae in an adult to be reported worldwide.
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Purpura fulminans (PF) was first described in 1886 and
characterized by the apparent shock and rapidly pro-
gressive symmetric peripheral gangrene caused by dis-
seminated intravascular coagulation [1]. Mortality of PF
patients is high (approximately 43%), and most survi-
vors require amputation of the affected extremities [2].
Neisseria meningitidis and Streptococcus pneumoniae are
typical causative organisms of PF [3]. However, Hemophi-
lus influenza is also a potential cause of the disease. The
delay in approval of the vaccine for H. influenzae type b
(Hib) and the emergence of various drug-resistant strains
became a concerning situation in Japan with regard to Hib
infection, which can be complicated by meningitis, en-
dophthalmitis, renal failure, and necrosis of the extrem-
ities. Here, we report a case of 41-year-old male who
succumbed to PF due to invasive H. influenzae infection
complicated by severe cardiomyopathy requiring extracor-
poreal membrane oxygenation (ECMO).* Correspondence: siris.accm@tmd.ac.jp
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Case report
A 41-year-old man presented to the emergency room
with complaints of fever, diarrhea, and fatigue for 24 h.
On examination, he was restless and his systolic blood
pressure, pulse, respiratory rate, and temperature were
50 mmHg, 143 beats/min, 30 breaths/min, and 38.2°C,
respectively. Oxygen saturation could not be recorded
because of peripheral circulatory failure. Marked cyan-
osis was evident in the facial region, peripheral limbs,
and penis. Lung auscultation revealed coarse breathing
sounds.
Arterial blood gas analysis was suggestive of remarkable
lactic acidosis with a serum lactate level of 11.5 mmol/L.
His white blood cell and platelet counts were low at
1,600/μL and 36,000/μL, respectively. Serum urea nitro-
gen (36.1 mg/dL), creatinine (4.8 mg/dL), and C-reactive
protein (25.6 g/dL) levels were elevated. Coagulation
was prolonged (prothrombin time, 50.9% of normal),
and fibrin/fibrinogen degradation product levels were
higher (98.9 μg/dL). Furthermore, his procalcitonin and
endotoxin levels were markedly elevated (457 ng/mL
and 548 pg/mL, respectively).
Computed tomography (CT) revealed left-sided sinus-
itis, bilateral lung consolidation, and an increasedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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quiring debridement or drainage were not evident. His
spleen was small, with a size of 38 cm3 on CT.
The observed cyanosis rapidly developed into purpura
within 1 h after arrival. Samples of blood, sputum, stool,
and urine were obtained for microbiological evaluation,
and imipenem/cilastatin (IPM/CS) was administered as
empirical therapy (0.5 g q12h). His blood pressure con-
tinued to decline despite the infusion of large amounts
of fluid and catecholamines. His carotid pulse was non-
palpable 1 h after the arrival. Recovery of spontaneous
circulation was achieved after 2 min of resuscitation.
Narrow QRS sinus tachycardia without ST-T changes
was apparent on electrocardiography. Decision to intro-
duce veno-arterial ECMO (V-A ECMO) was made be-
cause of prolonged hemodynamic catastrophe.
Approximately 12 h after admission, his pulse pressure
was undetectable and no cardiac contraction could be
discerned by ultrasonography. However, we maintained
blood pressure and oxygenation at adequate levels with
the aid of V-A ECMO. PMX therapy was induced at
emergency room for elevated endotoxin level, but it was
not effective because there was no improvement of vital
signs in this case.
Three days after hospitalization, cardiac function began
to improve, and the ejection fraction improved to 40% by
day 5. However, poor lung oxygenation persisted (PaO2/
FiO2 ratio was 50). To maintain oxygenation of the brain
and coronary arteries, we changed the support protocol
from V-A ECMO to veno-venous ECMO (V-V ECMO).Figure 1 Images of the patient was taken on the day 1 (A, B) and on
facial region, and penis progressed gradually, and all limbs complicated wiNotably, the creatine kinase (CK) MB levels were
261 IU/mL on day 1 of hospitalization; these levels grad-
ually increased to a peak of 417 IU/mL on day 3 before
gradually decreasing. These variations and the elevated
CK levels influenced the CK-MB/CK ratio, which was
1%–2% during the hospital stay.
A diagnosis of PF due to invasive H. influenzae infection
was made on the basis of the isolation of β-lactamase-
negative ampicillin-resistant (BLNAR) H. influenzae from
the patient's sputum and blood. Minimum inhibitory con-
centration values for antibiotics were as follows: ampicillin,
2 μg/mL; cefaclor, 16 μg/mL; cefotiam, 4 μg/mL; cefpodox-
ime proxetil, 8 μg/mL; and cefozopran, 16 μg/mL.
On day 9 of hospitalization, infection-induced necrotic
tissue in the limbs was clinically suspected (Figure 1), ne-
cessitating bilateral above-knee amputation and right fore-
arm and left upper arm amputation. As the necrotic areas
were not clearly demarcated, the stumps were not closed
and daily debridement and irrigation was performed.
The patient's respiratory condition gradually improved
thereafter, and he was successfully weaned from V-V
ECMO on day 12 of hospitalization. However, on the
same day, the patient developed left pneumothorax com-
plicated by persistent air leakage, which resulted in empy-
ema caused by methicillin-resistant Staphylococcus aureus.
He improved enough to leave the catecholamines once,
but septic shock due to empyema was rekindled. As oxy-
genation was too bad to perform isolated lung perfusion,
surgical lavage and drainage were impossible. Daily lavage
from a chest tube was performed, but he eventuallythe day 9 (C) of hospitalization. Gangrene of the bilateral limbs, the
th infection on the day 9.
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Discussion
Here, we reported a case of PF caused by H. influenzae
in a previously healthy adult. We conducted a literature
search and found that approximately 20 pediatric cases
and only one adult case have been reported [4]. The
adult case of PF caused by H. influenzae was reported in
2006 and involved a 34-year-old man. Although he re-
quired bilateral lower limb and fingertip amputation, he
managed to survive. As per our knowledge, our patient
may be only the second such case reported worldwide.
The pathophysiology of PF is ischemia caused by dis-
seminated intravascular coagulation (DIC). Though co-
agulation factor replacement strategies have been tested
in several clinical trials, there is no established therapy
for DIC. There have been reports that the congenital or
secondary decrease of protein C are involved in the
pathogenesis of PF. Additionally, there are reports of ef-
fective administration of activated protein C, which has
not been approved in Japan [5]. The administration of 8
to 12 mL/kg of fresh frozen plasma (FFP) is effective for
PF and protein C supplementation [6]. In the present
case, 24 mL/kg of FFP was administered on the first day,
but there was no obvious improvement. Recombinant
thrombomodulin (rTM), which binds to thrombin in vivo
and controls the ability to activate platelet function and fi-
brin formation, has been approved for DIC associated
with sepsis in Japan. Moreover, there is a case report of
limb salvage upon administration of rTM [7]. In our case,
ECMO was introduced for a significant cardiac dysfunc-
tion, so rTM could not be used due to the high risk of
bleeding.
Risks of this disease include hypoplasia of the spleen
and post-splenectomy. In this case, splenic volume was
38 cm3 on CT, and the average splenic volume in adults is
131 cm3 [8]. However, splenic volume is difficult to judge,
because of large individual differences and changes at any
given time in the same individual. In the present case,
Howell-Jolly bodies were not observed in the hemogram.
Hib vaccination was initiated in the 1980s, and the in-
cidence of invasive hemophilus infection has greatly de-
creased since then, with the added benefit of herd effects
[5]. In Japan, however, Hib vaccination was not initiated
until December 2008. Furthermore, the emergence of
drug-resistant H. influenzae is a concerning issue in
Japan, with up to 37.8% strains identified to be BLNAR
[9]. In our patient, IPM/CS was administered as initial
empirical therapy; however, the antibacterial effect of
IPM/CS against H. influenzae is thought to be weak
compared with that of other carbapenems [10]. There-
fore, a different regime could have been used for man-
aging the invasive hemophilus infection in our patient.The surgical procedure and its timing are still contro-
versial. Lerolle et al. recently reported the presence of
bacteria in the damaged vascular wall of necrotic tissues
[11]. However, previous literatures suggested that the
main cause of necrosis is ischemia due to sepsis-induced
DIC because of no bacteria in the necrotic tissues of PF.
In addition, Johansen et al. did not recommend early
amputation because the necrotic area of PF is gradually
localized [12]. We planned the first operation after de-
marcating the necrotic area. However, necrotic tissues
became to be infectious, so we were forced to perform
amputations as a source control of infection. There are
some reports about limb salvage managed by debridement
and negative pressure wound therapy to the limited nec-
rotic area caused by PF. In this case, intraoperative find-
ings showed that muscles were extensively devastated.
The height of amputation was determined by the muscle
color and ability of contraction, and signs of infection.
To the best of our knowledge, there have been no
other reports of severe cardiac dysfunction associated
with PF. Several etiologies could have been responsible
for the cardiac dysfunction in our patient. Stunned myo-
cardium, bacterial myocarditis, and stress-induced car-
diomyopathy are unlikely as the pathogenesis of cardiac
dysfunction in this case. Because he did not show rele-
vant changes of electrocardiography, pericardial effusion,
or elevated cardiac enzyme levels, we assume that the
possibility of septic cardiomyopathy is most probable in
this case. Septic cardiomyopathy is characterized by de-
fects in both the structure and function of the heart as a
result of myocardial edema. Such defects include mito-
chondrial dysfunction, the collapse of myocardial micro-
structures, or both. These problems are associated with
increased vascular permeability and elevated inflamma-
tory cytokine levels [13]. Symptoms are evident even in
the early stages of sepsis and are reversible. Septic car-
diomyopathy is characterized by a decrease in ejection
fraction attributable to diffuse hypokinesis of the left
ventricular wall and a compensatory increase in the end-
diastolic volume of the left ventricle. Cardiac index typ-
ically rises as a compensatory mechanism.
Several studies in animals have found that excessive
levels of certain cytokines, including tumor necrosis
factor-α, and interleukin-1β, induce cardiac dysfunction.
Excessive nitric oxide and calcium levels are also reported
to contribute to the development of such dysfunction, but
these findings require corroboration [13,14]. Recovery of
cardiac function occurs over approximately 10 days in pa-
tients who survive an episode of septic cardiomyopathy.
Our patient exhibited temporal worsening followed by a
recovery in cardiac function; this is usually expected in pa-
tients with septic cardiomyopathy. However, he never dis-
played hyperdynamic state of typical sepsis development.
Although our patient was atypical, we suggest that his
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nisms related to septic cardiomyopathy.
Recently, usefulness of V-A ECMO has been reported
in adult patients with sepsis [15]. In our case, ECMO
had some curative effect for septic cardiomyopathy since
the patient was not lost in the emergency room and
could withstand the therapy for infectious disease. How-
ever, an overall evaluation of ECMO for septic cardiomy-
opathy is void because the patient eventually died.
Conclusion
We reported the case of an adult male patient, possibly
the second reported adult case till date, who developed PF
caused by H. influenzae. His condition was complicated
by reversible cardiomyopathy. The initial management
with V-A ECMO was effective for early hemodynamic
catastrophe, but he eventually succumbed to sepsis with
empyema.
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